COMP <GO>
XNCR vs AUPH // ALTMAN Z-SCORE & DEBT/EQUITY
Xencor Inc. (NASDAQ) VS. Aurinia Pharmaceuticals Inc (NASDAQ) • 15-METRIC TALLY: XNCR 2
— AUPH 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: AUPH
LAST: $29.66 (-0.54%) • MKT CAP: $2.22B
balance-sheet
4.32
LAST: $16.14 (-3.06%) • MKT CAP: $2.22B
balance-sheet
8.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XNCR VS. AUPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XNCR | AUPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.30% | 16.50% | -37.80 | AUPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.37% | 5.92% | -12.29 | AUPH | /fcf-yield <GO> |
| Operating Margin | -60.00% | 37.10% | -97.10 | AUPH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 68.00% | -128.00 | AUPH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.70% | 20.40% | -6.70 | AUPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.32 | 8.33 | -4.01 | AUPH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | AUPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.2 | 49.1 | +17.10 | XNCR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.22B | $2.22B | $1.9M | XNCR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XNCR REV | AUPH REV | XNCR GROSS % | AUPH GROSS % | XNCR FCF | AUPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $125.6M | $283.1M | — | 88.5% | -$138.3M | $135.7M |
| FY 2024 | $110.5M | $235.1M | — | 88.0% | -$208.3M | $44.4M |
| FY 2023 | $174.6M | $175.5M | — | — | -$77.9M | -$33.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XNCR // BETA —
AUPH // BETA —